These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27533984)

  • 1. New oral anticoagulants: a practical guide for physicians.
    Hinojar R; Jiménez-Natcher JJ; Fernández-Golfín C; Zamorano JL
    Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):134-45. PubMed ID: 27533984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Steffel J; Verhamme P; Potpara TS; Albaladejo P; Antz M; Desteghe L; Haeusler KG; Oldgren J; Reinecke H; Roldan-Schilling V; Rowell N; Sinnaeve P; Collins R; Camm AJ; Heidbüchel H;
    Eur Heart J; 2018 Apr; 39(16):1330-1393. PubMed ID: 29562325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anticoagulants for stroke prevention in patients with atrial fibrillation.
    Jalota A; Scarabelli TM; Saravolatz L; Bakhsh MU; Agrawal P; Jalota R; Chen-Scarabelli C; Fuster V; Halperin J
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):247-62. PubMed ID: 24842559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Vitamin K Antagonist Oral Anticoagulants: The Clinician's New Challenge.
    Yorkgitis BK; Zhang J; Rappold JF
    J Am Osteopath Assoc; 2015 Oct; 115(10):612-21. PubMed ID: 26414714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation.
    Rivera-Caravaca JM; Esteve-Pastor MA; Roldán V; Marín F; Lip GYH
    Expert Opin Drug Saf; 2017 Sep; 16(9):1051-1062. PubMed ID: 28678553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
    Humbert X; Roule V; Chequel M; Fedrizzi S; Brionne M; Lelong-Boulouard V; Milliez P; Alexandre J
    Int J Cardiol; 2016 Nov; 222():1079-1083. PubMed ID: 27514627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K; Lip GY
    Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical considerations in the use of novel oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation.
    Deitelzweig S
    Cardiovasc Ther; 2014 Apr; 32(2):74-81. PubMed ID: 24119252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
    Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
    Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P;
    Europace; 2013 May; 15(5):625-51. PubMed ID: 23625942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial.
    De Caterina R; John Camm A
    Europace; 2016 Jan; 18(1):6-11. PubMed ID: 26450845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.
    Raparelli V; Proietti M; Cangemi R; Lip GY; Lane DA; Basili S
    Thromb Haemost; 2017 Jan; 117(2):209-218. PubMed ID: 27831592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin K and non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life.
    Giustozzi M; Vedovati MC; Verdecchia P; Pierpaoli L; Verso M; Conti S; Cianella F; Marchesini E; Filippucci E; Agnelli G; Becattini C
    Eur J Intern Med; 2016 Sep; 33():42-6. PubMed ID: 27394924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-vitamin K oral anticoagulants in atrial fibrillation: Where are we now?
    Dzeshka MS; Lip GY
    Trends Cardiovasc Med; 2015 May; 25(4):315-36. PubMed ID: 25440108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants.
    Dalal J; Bhave A; Oomman A; Vora A; Saxena A; Kahali D; Poncha F; Gambhir DS; Chaudhuri JR; Sinha N; Ray S; Iyengar SS; Banerjee S; Kaul U;
    Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S13-34. PubMed ID: 26688149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation - Messages from the 2018 EHRA.
    Tomaszuk-Kazberuk A; Kołtowski L; Balsam P; Koziński M; Kapłon-Cieślicka A; Kupczyńska K; Domienik-Karłowicz J; Budaj-Fidecka A; Buszman P; Wybraniec M; Burchardt P; Michalski B; Jaguszewski MJ
    Cardiol J; 2018; 25(4):423-440. PubMed ID: 30211927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.